Stryker launches ‘InSpace’, a subacromial balloon implant, in India

New Delhi: Stryker, a medical device company, announced the launch of InSpace, a biodegradable subacromial balloon implant for arthroscopic treatment of massive irreparable rotator cuff tears (MIRCTs), in India.

The InSpace balloon implant is designed to restore the subacromial space without requiring sutures or fixation devices and has been demonstrated to improve shoulder motion and function and provides a new option for surgeons in their shoulder continuum of care that allows them to better meet the needs of their patients, the company said in a statement.

The statement further added that the new balloon implant has a long successful clinical history of over 14 years and some of its key clinically proven advantages include that it offers a less invasive, streamlined surgical solution for MIRCTs compared to other surgical treatment options. On an average, patients showed an increase in range of motion compared to partial repair patients following surgery with long-term safety.

“InSpace is a, first-of-its-kind technology, offering a new, minimally invasive surgical option for surgeons, addressing their unmet needs in MIRCT and potentially providing early functional recovery and pain relief for patients,” said Aman Rishi, Vice President and General Manager, Stryker in India.